Peer Reviewed

Foreword from the Supplement Editors

Professor Gemma Figtree MBBS, DPhil (Oxon), FRACP, FCSANZ, FAHA, Professor Louise Burrell MBChB, MRCP, MD, FRACP, FAHA

Professor Gemma Figtree MB BS, DPhil (Oxon), FRACP, FCSANZ, FAHA

Professor in Medicine at The University of Sydney; and Professor of Medicine Northern Clinical School at Kolling Institute of Medical Research, Sydney, NSW.

Professor Figtree co-leads the Cardiovascular Theme for Sydney Health Partners, an NHMRC Advanced Health Research and Translation Centre, and is the Chair of The University of Sydney’s multidisciplinary Cardiovascular Initiative. She is also President of the Australian Cardiovascular Alliance and Chair of the Mission for the Medical Research Future Fund Cardiovascular Health Expert Advisory Panel.

 

Professor Louise Burrell MB ChB, MRCP, MD, FRACP, FAHA

Professor of Medicine at the University of Melbourne; and Head of Medical Unit 4 and  Director of Research in General Medicine at the Austin Hospital in Melbourne Vic;  and a Board Member of the Institute of Breathing and Sleep. At the University of Melbourne, she heads the Cardiovascular Research Group,  a multidisciplinary team of scientists, physicians and PhD students. She has held major roles  with the International Society of Hypertension, including Vice President, Treasurer and  Chair of the International Forum and Regional Advisory Groups.

Cardiometabolic disease describes a spectrum of common but often preventable conditions that pose a significant health and economic burden. Advances in screening and investigation to identify predisposing and contributing risk factors pave the way for preventive management in patients. Furthermore, the emergence of new therapies and approaches in diabetes, hypertension, hypercholesterolaemia and kidney disease will result in an enhanced toolkit in our fight against cardiometabolic disease.

This supplement contains five articles that explore approaches to the diagnosis, management and treatment of a range of conditions that increase an individual’s cardiovascular risk, including hypertension, type 2 diabetes, hypercholesterolaemia, kidney disease and obesity.

We hope that this supplement, which brings together diverse expert authors, will provide GPs and other healthcare professionals with a clinically relevant update to enhance the cardiometabolic health of their patients.